SA Quant ranks UBS' 26 highest conviction names for 2026
Source: SeekingAlpha
2025-12-17 13:36:48 ET
More on markets
- Apollo highlights stagflation concerns as the Fed balances inflation and jobs risks for 2026
- Energy is second worst-performing sector YTD, but some stocks buck the trend, led by Valero
- S&P 500 tech sector soars 21% YTD, with Sandisk as best performer
- Chip champions: Wall Street's 10 best-performing semiconductor stocks of 2025
- BlackRock maps the Fed path into 2026, calling for cautious cuts towards 3%
Read the full article on Seeking Alpha
For further details see:
SA Quant ranks UBS' 26 highest conviction names for 2026
ACADIA Pharmaceuticals Inc.
NASDAQ: ACAD
ACAD Trading
-1.34% G/L:
$21.025 Last:
573,736 Volume:
$21.41 Open:
ACAD Latest News
March 12, 2026 04:05:00 pm
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
March 09, 2026 09:54:00 am
Neuropsychiatric Innovation Draws Big Pharma Interest and Fresh Investment
March 03, 2026 04:05:00 pm
Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors
ACAD Stock Data
$3,864,112,700
124,348,635
0.05%
128
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
